Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

August 14, 2024

https://www.globenewswire.com/news-release/2024/08/13/2929195/0/en/Microbot-Medical-Receives-Quality-Certification-to-Support-Future-Regulatory-Submissions-and-Commercialization.html

BRAINTREE, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq:MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces it has received ISO 13485:2016 certification for its quality management system. Receiving ISO 13485 certification indicates that a company has developed and implemented robust policies and procedures for the development and manufacture of regulated medical products.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.